시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 개 관절염 치료 시장 보고서(2025년)
Canine Arthritis Treatment Global Market Report 2025
상품코드 : 1793433
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,469,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,350,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,232,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

개 관절염 치료 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 5.0%를 나타내 30억 1,000만 달러로 성장할 전망입니다. 예측기간의 성장은 반려동물 보험 가입률 상승, 관절염 증례 증가, 반려동물 사육률 상승, 침습 수술 수요 증가, 개 관절염 유병률 증가 등에 기인하고 있습니다. 예측기간의 주요 동향은 혁신적 치료, 수의학 진보, 고급 치료에 대한 수요, 기술 통합, 혁신적 기술 등입니다.

향후 5년간의 성장률 5.0%라고 하는 예측은 전회의 예측으로부터 0.2%의 미감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 중국산 글루코사민과 콘드로이틴 황산원약에 대한 수입세 인상은 관절용 건강식품 씹을 수 있는 제제 비용을 상승시킵니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

개 관절염 치료 시장은 반려동물 사육률 증가로 성장할 것으로 보입니다. 반려동물 사육에는 교우와 즐거움을 위해 가축을 돌보는 것이 포함되며, 라이프 스타일 변화, 반려동물의 인간화, 가처분 소득 증가 등의 요인이 동향 상승에 기여하고 있습니다. 반려동물 주인은 개 관절염 치료를 이용하여 증상을 관리하고 개 생활의 질과 운동 능력을 향상시킵니다. 예를 들어, 2023년 10월 미국 반려동물 용품협회(American Pet Products Association)는 미국 가구의 66%, 총 8,690만 명이 반려동물을 소유하고 있다고 보고했으며, 반려동물 소유 증가가 개 관절염 치료 시장을 견인하고 있음을 나타냅니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Canine arthritis treatment involves various medical and therapeutic approaches aimed at addressing the chronic condition characterized by inflammation and progressive cartilage deterioration in a dog's joints. The goal is to reduce pain and inflammation, preserve joint function, and slow down disease progression.

The primary treatments for canine arthritis include drugs, supplements, surgical procedures, and other interventions. Canine arthritis drugs are medications specifically formulated to alleviate symptoms and manage arthritis in dogs. These drugs can be administered orally, parenterally (such as injections), or through other routes, targeting conditions such as osteoarthritis, rheumatoid arthritis, osteochondrosis, and traumatic arthritis. They are distributed through veterinary clinics, hospitals, retail pharmacies, and online platforms, catering to various end-users such as veterinary hospitals, drug stores, and e-commerce platforms.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a considerable impact on the veterinary healthcare sector, particularly in the supply of pharmaceuticals, medical devices, and animal care products. Increased duties on imported veterinary medicines, diagnostic equipment, surgical tools, and pet care supplies have driven up operational costs for veterinary clinics, animal hospitals, and livestock health providers, forcing them to either raise service charges or absorb reduced profit margins. The livestock and agricultural industries are facing similar pressures, as tariffs on feed additives, vaccines, and breeding equipment push up production costs and complicate animal health management. Furthermore, retaliatory tariffs in major export markets have weakened demand for U.S.-manufactured veterinary products, adding to revenue challenges. To navigate these headwinds, the sector must now focus on local sourcing, preventive healthcare strategies, and digital veterinary solutions to control costs while continuing to deliver quality animal care.

The canine arthritis treatment research report is one of a series of new reports from The Business Research Company that provides canine arthritis treatment market statistics, including the canine arthritis treatment industry's global market size, regional shares, competitors with a canine arthritis treatment market share, detailed canine arthritis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the canine arthritis treatment industry. This canine arthritis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The canine arthritis treatment market size has grown strongly in recent years. It will grow from $2.35 billion in 2024 to $2.47 billion in 2025 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to the aging pet population, growing awareness among pet owners, focus on preventive care, increasing disposable income, and increasing veterinary care expenditure.

The canine arthritis treatment market size is expected to see strong growth in the next few years. It will grow to $3.01 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to a rise in pet insurance coverage, growing cases of arthritis, rising pet ownership rates, growing demand for minimally invasive surgical procedures, and increasing prevalence of arthritis in dogs. Major trends in the forecast period include innovative treatments, advancements in veterinary medicine, demand for advanced therapies, integration of technology, and innovative technologies.

The forecast of 5.0% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Higher import taxes on Chinese glucosamine and chondroitin sulfate APIs will increase formulation costs for joint-health chewables. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The canine arthritis treatment market is set to grow, driven by the increasing rate of pet ownership. Pet ownership involves caring for domesticated animals for companionship and enjoyment, with factors such as lifestyle changes, pet humanization, and higher disposable incomes contributing to the rising trend. Pet owners utilize treatments for canine arthritis to manage symptoms and improve their dogs' quality of life and mobility. For example, in October 2023, the American Pet Products Association reported that 66% of US households, totaling 86.9 million, owned a pet, indicating the growth in pet ownership driving the canine arthritis treatment market.

Leading companies in this market are innovating treatments such as bedinvetmab injections to address canine joint health and mobility. Bedinvetmab, a monoclonal antibody injection targeting nerve growth factor (NGF) involved in pain, has gained FDA approval. For instance, in May 2023, Zoetis Inc. received FDA approval for Librela, the first monoclonal antibody for dogs, which inhibits canine NGF's biological activity related to pain regulation in osteoarthritis. Administered monthly via subcutaneous injection, Librela offers a convenient, long-term solution for managing canine osteoarthritis pain.

In September 2024, Zoetis, a US-based animal health company specializing in veterinary pain management solutions, partnered with the Arthritis Foundation to raise awareness about osteoarthritis (OA) in pets. This collaboration aims to support educational initiatives that help pet owners identify OA symptoms in dogs and cats, providing tools to improve early detection and manage OA-related pain effectively. The Arthritis Foundation is a US-based nonprofit organization dedicated to the prevention, control, and cure of America's leading cause of disability.

Major companies operating in the canine arthritis treatment market are Merck & Co. Inc., Bayer AG, Eli Lilly and Company, Zoetis Inc., Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Royal Canin SAS, Virbac Group, Ceva Sante Animale S.A., Hill's Pet Nutrition Inc., Vetoquinol SA, Norbrook Laboratories Limited, American Regent Inc., Thorne Healthtech Inc., VetStem Inc., Eltech K-Laser s.r.l., Liquid Health Inc, Nutri-Vet LLC, OrthoPets LLC, Rejuvenate Bio Inc.

North America was the largest region in the canine arthritis treatment market in 2024. Asia-Pacifica is expected to be the fastest-growing region in the forecast period. The regions covered in the canine arthritis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the canine arthritis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The canine arthritis treatment market includes revenues earned by entities by providing services such as extracorporeal shockwave therapy (ESWT), acupuncture, and hyaluronic acid supplements. The market value includes the value of related goods sold by the service provider or included within the service offering. The canine arthritis treatment market also includes sales of gabapentin, adequan canine, and metacam. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Canine Arthritis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on canine arthritis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for canine arthritis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The canine arthritis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Canine Arthritis Treatment Market Characteristics

3. Canine Arthritis Treatment Market Trends And Strategies

4. Canine Arthritis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Canine Arthritis Treatment Growth Analysis And Strategic Analysis Framework

6. Canine Arthritis Treatment Market Segmentation

7. Canine Arthritis Treatment Market Regional And Country Analysis

8. Asia-Pacific Canine Arthritis Treatment Market

9. China Canine Arthritis Treatment Market

10. India Canine Arthritis Treatment Market

11. Japan Canine Arthritis Treatment Market

12. Australia Canine Arthritis Treatment Market

13. Indonesia Canine Arthritis Treatment Market

14. South Korea Canine Arthritis Treatment Market

15. Western Europe Canine Arthritis Treatment Market

16. UK Canine Arthritis Treatment Market

17. Germany Canine Arthritis Treatment Market

18. France Canine Arthritis Treatment Market

19. Italy Canine Arthritis Treatment Market

20. Spain Canine Arthritis Treatment Market

21. Eastern Europe Canine Arthritis Treatment Market

22. Russia Canine Arthritis Treatment Market

23. North America Canine Arthritis Treatment Market

24. USA Canine Arthritis Treatment Market

25. Canada Canine Arthritis Treatment Market

26. South America Canine Arthritis Treatment Market

27. Brazil Canine Arthritis Treatment Market

28. Middle East Canine Arthritis Treatment Market

29. Africa Canine Arthritis Treatment Market

30. Canine Arthritis Treatment Market Competitive Landscape And Company Profiles

31. Canine Arthritis Treatment Market Other Major And Innovative Companies

32. Global Canine Arthritis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Canine Arthritis Treatment Market

34. Recent Developments In The Canine Arthritis Treatment Market

35. Canine Arthritis Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기